Home Add to Favorite Contact Submit  
           28 March, 2024


    
Category:  Press » Kids & Teens

 

New Genes Found for Inflammatory Bowel Disease in Children

Popularity:
         Views: 1662
2008-08-31 21:29:58     
Children's Hospital of Philadelphia

Researchers have discovered two new genes that increase the risk of developing inflammatory bowel disease (IBD) in childhood.

While further study is needed to identify the specific disease-causing mutations in these new genes, the researchers say the genes are particularly strong candidates to be added to the list of genes already known to affect IBD. "As we continue to find genes that interact with each other and with environmental influences in this complex, chronic disease, we are building the foundation for personalized treatments tailored to a patient's genetic profile," said co-first author Robert N. Baldassano, M.D., director of the Center for Pediatric Inflammatory Bowel Disease at The Children's Hospital of Philadelphia.

"We will resequence the gene regions we have identified to pinpoint the causative mutations in these genes," added study leader Hakon Hakonarson, M.D., Ph.D., director of the Center for Applied Genomics at Children's Hospital. "We strongly suspect one gene will provide a compelling target for drug development, given what's known about its biology."

Both authors direct research programs at Children's Hospital and are also faculty members of the University of Pennsylvania School of Medicine. Their study, performed in collaboration with researchers from the Medical College of Wisconsin, The University of Utah, Cincinnati Children's Hospital and two research hospitals in Italy, appears in advance online publication Aug. 31 in Nature Genetics.

IBD is a painful, chronic inflammation of the gastrointestinal tract, affecting about two million children and adults in the United States. Of that number, about half suffer from Crohn's disease, which can affect any part of the gastrointestinal tract, and half have ulcerative colitis, which is limited to the large intestine.

IBD that begins in childhood tends to be more severe than adult-onset disease, and is more likely to affect the colon than other areas of the GI tract. Those age-related differences in IBD spurred the current research team to do their gene hunting in childhood-onset disease. "Although the gene variants we found may have a stronger signal in pediatric IBD than in adult- onset IBD, we do not believe them to be limited to varieties of the disease that begin in childhood," said Baldassano.

The researchers performed a genome-wide association study, searching for genetic variations in DNA samples from 1,000 patients with childhood-onset IBD, compared to samples from 4,250 healthy subjects. Both patients and controls were of European ancestry.

In addition to finding gene variations previously reported by other groups, the study team identified two novel gene variants, one on chromosome 20 and the other on chromosome 21. They then replicated their findings with studies using additional samples from other sources.

The researchers say that the TNFRSF6B gene on chromosome 20 is a compelling candidate, because it is already known to participate in the biological pathway of a protein called tumor necrosis factor (TNF). TNF is a cytokine, a chemical messenger that plays a key role in the harmful inflammation characteristic of IBD.

Some current treatments for IBD use monoclonal antibodies that selectively bind to a type of TNF involved in the disease (Among those drugs are infliximab, adalimumab and certolizumab). "As we better understand the complex gene interactions in IBD, we may be able to diagnose patients by their genetic profile to predict who will better respond to anti-TNF drugs," said Hakonarson. Anti-TNF medications such as those mentioned above are currently given intravenously or as injections, said Baldassano, who added, "If better knowledge of the disease pathway enables pharmaceutical companies to develop anti-TNF drugs in pill form, the medications will be easier to deliver as well as more customized to each patient."

The study team also found an association between ulcerative colitis and genes on the major histocompatiblity complex (MHC) on chromosome 6. The MHC is a large group of genes with important roles in the immune system, and this finding may help refine diagnostic techniques that would allow physicians to administer more specific therapies to their patients.

The Center for Pediatric Inflammatory Bowel Disease at Children's Hospital currently treats 1,400 children annually for IBD, and has one of the world's largest clinical research programs for IBD. The Center for Applied Genomics, directed by Hakonarson, is currently the largest pediatric genotyping program in the world. The Center's highly automated analytic equipment scans each DNA sample for over half a million genetic markers.

Financial support for the study came from the National Institutes of Health, the IBD Family Research Council, the Crohn's and Colitis Foundation of America, the Koss Foundation, the NIH General Clinical Research Center of the Medical College of Wisconsin, the Primary Children's Medical Center Foundation, the Edmunds Fund, the Heineman Foundation, the Cotswold Foundation, and The Children's Hospital of Philadelphia, which funded all genotyping performed in the study.

Baldassano's and Hakonarson's co-authors included Struan Grant, Ph.D., Jonathan Bradfield, Ph.D., David A. Piccoli, M.D., Petar Mamula, M.D., Robert Grundmeier, M.D., and Dimitri Monos, Ph.D., all of Children's Hospital. Other co-authors were Subra Kugathasan, M.D. (formerly of the Medical College of Wisconsin and currently at Emory University), who is co-first author with Baldassano; Stephen Guthery, M.D., of the University of Utah; Gitit Tomer, M.D., and Lee Denson, M.D., of Cincinnati Children's Hospital Medical Center; Salvatore Cucchiara, M.D., Ph.D., of Sapienza University, Rome, Italy; and Vito Annese, M.D., of "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, Italy.

About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking third in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 430-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.

CONTACT: Rachel Salis-Silverman

Phone: (267) 426-6063

Specialized in: Hospital - Pediatric - Child - Infant - Toddler - Teen - Adolescent - Baby - Teenager - Surgery - Healthcare - Pediatrician - Pennsylvania - Delaware - Delaware Valley
URL: http://www.chop.edu
Print press release      Bookmark this page
Related Press releases 
Peanuts Celebrates 60 Years (Popularity: ): Saturday, October 2 marks the 60th anniversary of PEANUTS by Charles M. Schulz. First launched in only seven papers, the comic strip now appears in over 2,200 newspapers, in 75 countries and 21 languages. PEANUTS animated specials have become a seasonal tradition and thousands of consumer products are available in virtually all retail channels. Charlie Brown kicking the football, Linus and his blanket and Lucy leaning over Schroeder's piano are ...
YWCA Greater Los Angeles Honors Venus Williams with Phenomenal Woman of the Year Award (Popularity: ): The YWCA Greater Los Angeles (YWCA GLA) will honor multiple grand slam tennis champion and entrepreneur Venus Williams at its upcoming Phenomenal Woman Awards Luncheon on Tuesday, July 13, 2010 from 11:30am - 2pm. The event will be held in downtown Los Angeles at the Millennium Biltmore Hotel at 500 S. Grand Avenue and is themed "Saluting Women who Change the Game".The Phenomenal Woman Awards fundraiser draws Southern California's top ...
World's Youngest Editor-in-Chief 11 Year old Ajha Nicole Dortch of Atlanta Travels to Tampa With her A.N.D. Magazine Collecting Shoes Benefiting Haiti Relief (Popularity: ): Ajha Nicole Dortch is the 11 year old Editor-in-Chief of A.N.D. Magazine. Launching what could be the first ever Pre-teen magazine by Pre-teens and for Pre-teens.Since 2009 with her inaugural issue featuring independent women, then 10 year old Ajha Nicole Dortch has combined her love of writing with her love of fashion. "I've put my all into this magazine," says Ajha. "So why not call it by my name?" The ...
Writing Instrument Manufacturers Association Celebrates the History-Shaping Power of the Handwritten Word on John Hancock's Birthday, Jan. 23 (Popularity: ): The first signature on the Declaration of Independence on July 4, 1776 was also the most recognizable: that of John Hancock. To honor the influence handwriting has had on American history, the Writing Instrument Manufacturers Association has declared Hancock's birthday, Jan. 23, National Handwriting Day."Throughout history, handwritten documents have sparked love affairs, started wars, established peace, freed slaves, created movements and declared independence," stated WIMA Executive Director David H. Baker. ...
AT&T and Roadtrip Nation Inspire High School Students to Define Their Own Road in Life (Popularity: ): AT&T* announced today that it will support Roadtrip Nation (RTN) in its mission to help high school students define their own road in life through real-world career exploration experiences. Starting with the first East Coast program that launched today in New York City, AT&T will contribute $1.2 million to the Roadtrip Nation Experience through AT&T Aspire, which is AT&T's $100 million initiative focused specifically on high school success and workforce ...


Related Business 
Lippincott Williams & Wilkins - Inflammatory Bowel Disease (Popularity: ): Devoted exclusively to Inflammatory Bowel Diseases and covers topics of interest to professionals treating patients or conducting research on inflammatory bowel diseases.
Northwestern University Inflammatory Bowel Disease Center (Popularity: ): Consists of a team of gastroenterologists, radiologists, surgeons, pathologists, psychologists, and social workers who are specialized in the diagnosis, treatment, and emotional support of patients afflicted with Crohn's Disease, Ulcerative Colitis, and other Inflammatory Bowel Diseases.
Irritable Bowel Syndrome and Inflammatory Bowel Disease (Popularity: ): A huge resource for these disorders, including original articles, chat, and links to information about medications, diet, symptoms, surgery, diagnostic testing, and more topics.
Crohn's and Colitis Pharmacist (Popularity: ): Drug and disease information on Crohn's disease, Ulcerative colitis, Inflammatory Bowel Disease. We provide drug and disease information. Questions are answered by a pharmacist who has Crohn's disease.
Accutane Lawsuit Lawyers (Popularity: ): In June of 2009, international pharmaceutical giant Hoffman-LaRoche discontinued the manufacture and distribution of its premier acne medication, Accutane (also known as Isotretinoin). This happened amid reports that the drug is linked to a number of serious and incurable diseases, including Crohn's Disease and inflammatory bowel disease.
Amsterdam Molecular Therapeutics (Popularity: ): Focused on developing gene therapies for lipoprotein lipase disorder, inflammatory bowel disease and neuroregeneration. Also provides contract development and manufacturing of gene and cell-based products in their GMP facility.
Inner Relief for Crohns and Colitis Sufferers (Popularity: ): A natural food product with high levels of natural anti-inflammatories, giving relief to sufferers of inflammatory bowel disease.
Atlantic Gastroenterology Associates, PA. & Atlantic Gastro Surgicenter, LLC. (Popularity: ): Gastroenterology practice based in New Jersey (Egg Hrbor Township, Absecon, Ventor City) which provides diagnostic and therapeutic endoscopy, colo-rectal screening, hepatitis therapy, inflammatory bowel disease therapy, and nutritional support.
The Children's Fund for Glycogen Storage Disease Research (Popularity: ): This not-for-profit foundation has been established to benefit children born with Glycogen Storage Disease, Type 1a (GSD1a.) Our goal is to help find a cure for this disease.
Children's Liver Disease Foundation (Popularity: ): Information and support for families of children with liver disease, inc. jaundice and hepatitis, research into causes and treatment, fact-sheets and study days for health professionals UK based.